History of sexually transmitted infections among mpox cases in the 2022 outbreak in Spain

IF 3.2 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2026-09-06 Epub Date: 2026-06-19 DOI:10.1111/hiv.70270
Aina March-Yagüe, Diana Toledo, Asunción Díaz, Pere Godoy, Olaia Pérez-Martínez, Carles Pericas, Alonso Sanchez-Migallon, María Dolores Chirlaque, Jesús Ospina, María Grau, Francisco Roig, Angela Domínguez, and the MONKPOX-ESP22 Subproject 3.2 Working Group
{"title":"History of sexually transmitted infections among mpox cases in the 2022 outbreak in Spain","authors":"Aina March-Yagüe,&nbsp;Diana Toledo,&nbsp;Asunción Díaz,&nbsp;Pere Godoy,&nbsp;Olaia Pérez-Martínez,&nbsp;Carles Pericas,&nbsp;Alonso Sanchez-Migallon,&nbsp;María Dolores Chirlaque,&nbsp;Jesús Ospina,&nbsp;María Grau,&nbsp;Francisco Roig,&nbsp;Angela Domínguez,&nbsp;and the MONKPOX-ESP22 Subproject 3.2 Working Group","doi":"10.1111/hiv.70270","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>The aim was to describe the history of sexually transmitted infections (STIs) among adult mpox men cases and to analyse sociodemographic and epidemiological characteristics according to the presence or absence of any STI diagnosed 1 or 6 months previous to mpox diagnosis during the 2022 outbreak in Spain.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>A cross-sectional study was conducted as part of a multicentre study in seven Spanish regions. Mpox patients were enrolled by the epidemiological surveillance services from June 2022 to January 2023. We conducted descriptive and bivariate analyses to compare sociodemographic, epidemiological and clinical characteristics of mpox according to the presence of a previous STI diagnosis. Associations were assessed using logistic regression to estimate crude odds ratio (OR) and adjusted odds ratio (aOR) with 95% confidence intervals (95% CI).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 1202 mpox individuals were included (96.4% were men); 36% (417/1159) of males had previous STI during the 6 months previous to mpox diagnosis. Chemsex practice (aOR 1.66, 95% CI: 1.11–2.47), practicing sex in leisure places (aOR 1.68, 95% CI: 1.12–2.51), having HIV diagnosis (aOR 1.91, 95% CI: 1.32–2.77) and using pre-exposure prophylaxis (PrEP) (aOR 4.43, 95% CI: 3.05–6.45) were more frequent among males with a history of STI in the 6 months previous to mpox diagnosis. No statistical differences were found in mpox clinical manifestations and hospitalization according to STI history.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Overlapping risk behaviours and shared transmission routes contributed to the high prevalence of STI history in mpox cases. Epidemiological characteristics studied in mpox cases with previous STI may help identify target populations and planning an integrated prevention strategy.</p>\n </section>\n </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"27 9","pages":"1490-1502"},"PeriodicalIF":3.2000,"publicationDate":"2026-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.70270","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hiv.70270","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

The aim was to describe the history of sexually transmitted infections (STIs) among adult mpox men cases and to analyse sociodemographic and epidemiological characteristics according to the presence or absence of any STI diagnosed 1 or 6 months previous to mpox diagnosis during the 2022 outbreak in Spain.

Methods

A cross-sectional study was conducted as part of a multicentre study in seven Spanish regions. Mpox patients were enrolled by the epidemiological surveillance services from June 2022 to January 2023. We conducted descriptive and bivariate analyses to compare sociodemographic, epidemiological and clinical characteristics of mpox according to the presence of a previous STI diagnosis. Associations were assessed using logistic regression to estimate crude odds ratio (OR) and adjusted odds ratio (aOR) with 95% confidence intervals (95% CI).

Results

A total of 1202 mpox individuals were included (96.4% were men); 36% (417/1159) of males had previous STI during the 6 months previous to mpox diagnosis. Chemsex practice (aOR 1.66, 95% CI: 1.11–2.47), practicing sex in leisure places (aOR 1.68, 95% CI: 1.12–2.51), having HIV diagnosis (aOR 1.91, 95% CI: 1.32–2.77) and using pre-exposure prophylaxis (PrEP) (aOR 4.43, 95% CI: 3.05–6.45) were more frequent among males with a history of STI in the 6 months previous to mpox diagnosis. No statistical differences were found in mpox clinical manifestations and hospitalization according to STI history.

Conclusions

Overlapping risk behaviours and shared transmission routes contributed to the high prevalence of STI history in mpox cases. Epidemiological characteristics studied in mpox cases with previous STI may help identify target populations and planning an integrated prevention strategy.

西班牙2022年麻疹暴发期间的性传播感染史
目的:目的是描述成年mpox男性病例的性传播感染(STI)病史,并根据在mpox诊断前1个月或6个月是否诊断出任何STI来分析社会人口学和流行病学特征。方法:横断面研究作为西班牙七个地区多中心研究的一部分进行。流行病学监测部门于2022年6月至2023年1月登记了麻疹患者。我们进行了描述性和双变量分析,根据既往性传播感染诊断比较m痘的社会人口学、流行病学和临床特征。使用逻辑回归评估相关性,以95%置信区间(95% CI)估计粗优势比(OR)和调整优势比(aOR)。结果:共纳入mpox个体1202例(男性96.4%);36%(417/1159)的男性在m痘诊断前6个月内曾有过性传播感染。有性行为(aOR 1.66, 95% CI: 1.11-2.47)、休闲场所性行为(aOR 1.68, 95% CI: 1.12-2.51)、HIV诊断(aOR 1.91, 95% CI: 1.32-2.77)和使用暴露前预防(aOR 4.43, 95% CI: 3.05-6.45)在m痘前6个月内有性传播感染史的男性中更为常见。不同性传播感染史的mpox临床表现和住院率无统计学差异。结论:重叠的危险行为和共享的传播途径导致了m痘病例中性传播感染史的高发。研究既往性传播感染的m痘病例的流行病学特征可能有助于确定目标人群并规划综合预防战略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书